nach oben

Clinical & Experimental Metastasis

Erschienen in:

01.12.2009 | Research Paper

Strong expression of chemokine receptor CXCR4 by renal cell carcinoma cells correlates with metastasis

verfasst von: Linhui Wang, Liang Wang, Bo Yang, Qing Yang, Shouyi Qiao, Yingming Wang, Yinghao Sun

Erschienen in: Clinical & Experimental Metastasis | Ausgabe 8/2009

Einloggen, um Zugang zu erhalten

Abstract

The chemokine receptor CXCR4 is involved in the metastasis of many cancers. Recent evidence suggests that CXCR4 may be also involved in the metastasis of renal cell carcinoma. We analyzed the expression of CXCR4 in primary carcinomas, metastatic tissues and normal tissues using immunohistochemistry. We further investigated the migration of renal carcinoma cells in response to stimulation by CXCL12 in vitro. We also studied the subcellular localization of CXCR4 in renal cell carcinoma cells in response to CXCL12 by confocal microscopy. We observed the highest percentage of CXCR4 expression in renal cell carcinoma metastases compared with that in renal cell carcinomas and normal renal tissues. We further found that CXCR4 was localized predominantly in the membrane in primary renal cell carcinomas and predominantly in the cytoplasm in renal cell carcinoma metastases. Moreover, we found that CXCR4 was translocated from the cytoplasmic membrane to the cytoplasm upon stimulation by its ligand CXCL12. Renal cell carcinoma metastasis was associated with higher expression of CXCR4 and interaction of CXCR4 and its ligand CXCL12 resulted in the internalization of CXCR4 from the cytoplasmic membrane. These findings implicate the CXCR4-CXCL12 axis in the metastasis of renal cell carcinoma.

Landis SH et al (1999) Cancer statistics. CA Cancer J Clin 49(1):8–31CrossRefPubMed

Jones J, Libermann TA (2007) Genomics of renal cell cancer: the biology behind and the therapy ahead. Clin Cancer Res 1(2 Pt 2):685s–692sCrossRef

Nicolson GL (1993) Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis. Cancer Metastasis Rev 12(3–4):325–343CrossRefPubMed

Kucia M et al (2004) CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol 35(3):233–245CrossRefPubMed

Cohen HT, McGovern FJ (2005) Renal-cell carcinoma. N Engl J Med 353(23):2477–2490CrossRefPubMed

Butcher EC et al (1999) Lymphocyte trafficking and regional immunity. Adv Immunol 72:209–253CrossRefPubMed

Campbell JJ, Butcher EC (2000) Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr Opin Immunol 12(3):336–341CrossRefPubMed

Zlotnik A, Yoshie O (2000) Chemokines: a new classification system and their role in immunity. Immunity 12(2):121–127CrossRefPubMed

Muller A et al (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410(6824):50–56CrossRefPubMed

10.

Jiang SH et al (2008) Alternate arrangement of PpL B3 domain and SpA D domain creates synergistic double-site binding to VH3 and Vkappa regions of fab. DNA Cell Biol 27(8):423–431CrossRefPubMed

11.

Brand S et al (2005) CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation. Exp Cell Res 310(1):117–130CrossRefPubMed

12.

Struckmann K et al (2008) pVHL co-ordinately regulates CXCR4/CXCL12 and MMP2/MMP9 expression in human clear-cell renal cell carcinoma. J Pathol 214(4):464–471CrossRefPubMed

13.

Murphy PM (2001) Chemokines and the molecular basis of cancer metastasis. N Engl J Med 345(11):833–835CrossRefPubMed

14.

Begum NA et al (1999) Reduced expression of the CXCR4 receptor mRNA in hepatocellular carcinoma and lack of inducibility of its ligand alpha-chemokine hIRH/SDF1alpha/PBSF in vitro. Int J Oncol 14(5):927–934PubMed

15.

Sehgal A et al (1998) CXCR-4, a chemokine receptor, is overexpressed in and required for proliferation of glioblastoma tumor cells. J Surg Oncol 69(2):99–104CrossRefPubMed

16.

Rempel SA et al (2000) Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. Clin Cancer Res 6(1):102–111PubMed

17.

Schrader AJ et al (2002) CXCR4/CXCL12 expression and signalling in kidney cancer. Br J Cancer 86(8):1250–1256CrossRefPubMed

18.

Signoret N et al (1998) Differential regulation of CXCR4 and CCR5 endocytosis. J Cell Sci 111(Pt 18):2819–2830PubMed

19.

Kraitchman DL et al (2005) Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation 112(10):1451–1461CrossRefPubMed

20.

Nagasawa T, Kikutani H, Kishimoto T (1994) Molecular cloning and structure of a pre-B-cell growth-stimulating factor. Proc Natl Acad Sci USA 91(6):2305–2309CrossRefPubMed

21.

Signoret N et al (1997) Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4. J Cell Biol 139(3):651–664CrossRefPubMed

22.

Spano JP et al (2004) Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome. Ann Oncol 15(4):613–617CrossRefPubMed

23.

Pleass RJ et al (2001) Streptococcal IgA-binding proteins bind in the Calpha 2-Calpha 3 interdomain region and inhibit binding of IgA to human CD89. J Biol Chem 276(11):8197–8204CrossRefPubMed

24.

Haviv YS et al (2004) Transcriptional targeting in renal cancer cell lines via the human CXCR4 promoter. Mol Cancer Ther 3(6):687–691PubMed

25.

Schrader AJ et al (2002) CXCR4/CXCL12 expression and signalling in kidney cancer. Br J Cancer 86:1250–1256CrossRefPubMed

Titel: Strong expression of chemokine receptor CXCR4 by renal cell carcinoma cells correlates with metastasis
verfasst von: Linhui Wang
Liang Wang
Bo Yang
Qing Yang
Shouyi Qiao
Yingming Wang
Yinghao Sun
Publikationsdatum: 01.12.2009
Verlag: Springer Netherlands
Erschienen in: Clinical & Experimental Metastasis / Ausgabe 8/2009
Print ISSN: 0262-0898
Elektronische ISSN: 1573-7276
DOI: https://doi.org/10.1007/s10585-009-9294-3

Springer Medizin

Strong expression of chemokine receptor CXCR4 by renal cell carcinoma cells correlates with metastasis

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2009

Twist, an independent prognostic marker for predicting distant metastasis and survival rates of esophageal squamous cell carcinoma patients

Evaluation of metastatic and angiogenic potentials of human colon carcinoma cells in chick embryo model systems

MicroRNA-17-3p is a prostate tumor suppressor in vitro and in vivo, and is decreased in high grade prostate tumors analyzed by laser capture microdissection

Anti-metastatic effects of liposomal gemcitabine in a human orthotopic LNCaP prostate cancer xenograft model

Osteoblasts modulate Ca2+ signaling in bone-metastatic prostate and breast cancer cells

Prognostic value of indoleamine 2,3-dioxygenase expression in high grade osteosarcoma

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie